EN
HI
Natco Pharma Chart
Natco Pharma Share Key Metrics
Volume
21.38 L
Market Cap
18195.77 CR
LTQ@LTP
1@947.40
ATP
957.75
Var Margin
19.97 %
Circuit Range
812.8-1219
Delivery %
26.63 %
Value
204.74 CR
ASM/GSM
No
Market Lot
1
Summary
Natco Pharma share price is ₹947.4 as of 1 Jun, 2026. The stock Natco Pharma intraday movement has stayed between ₹937.00 and ₹1014.00, while on a 52-week basis,Natco Pharma price 52 week high is ₹1226.80 & its 52 week low is ₹789.00.
In terms of trading activity, Natco Pharma has recorded a volume of 2137754 shares, The Natco Pharma has a market cap of ₹179109870 CR. The stock’s Average Traded Price (ATP) stands at ₹957.75, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹947.40.
Natco Pharma operates within a circuit range of ₹812.80 – ₹1219.00, with a Value of ₹204.74 CR. The Delivery Percentage for the day is 26.63%. Additionally, Natco Pharma currently falls under the No framework, and trades with a market lot size of 1.
Natco Pharma Fundamentals
View MoreP/E Ratio
12.84
P/B Ratio
1.97
Div. Yield
0.49
Sector P/E
69.53
Sector P/B
2.99
Sec. Div. Yield
0.55
Natco Pharma Resistance and Support
Pivot 1072.6
Resistance
First Resistance
1145.2
Second Resistance
1274.5
Third Resistance
1347.1
Support
First Support
943.3
Second Support
870.7
Third Support
741.4
Natco Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results |
| 2026-03-24 | Scheme of Arrangement |
| 2026-02-12 | Quarterly Results & Interim Dividend |
| 2025-11-14 | Quarterly Results & Interim Dividend |
| 2025-08-12 | Quarterly Results & Interim Dividend |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results & Interim Dividend |
Natco Pharma News
Natco Pharma Q4 Results: Stock falls 9% as revenue drops 40%, margin shrinks
Natco Pharma reported a substantial decline in its Q4 performance, with revenue dropping by 40% and margins shrinking, which led to a fall in the company's stock price.
May 29 2026 14:39:42
Natco Pharma Ltd - 524816 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March, 2026
Natco Pharma's FY26 consolidated revenue declined 8.5% to ₹4,375.9 Cr, with net profit falling 24.7% to ₹1,418.5 Cr. This includes a ₹115 Cr one-time tax benefit from moving to a new tax regime. The board also approved the demerger of its Agro Chemical business.
May 29 2026 14:16:42
Read More
Natco Pharma Management
| Name | Position |
|---|---|
| Chekuri Venkat Ramesh | Company Secretary & Compliance Officer |
| V C Nannapaneni | Chairman & Managing Director |
Natco Pharma Similar Stocks
Pfizer Ltd.
4550.70
-47.80 (1.04%)
Onesource Specialty Pharma Ltd.
1842.00
17.40 (0.95%)
Eris Lifesciences Ltd.
1386.50
-12.50 (0.89%)
Granules India Ltd.
787.20
13.35 (1.73%)
Astrazeneca Pharma India Ltd.
8748.00
116.50 (1.35%)
Cohance Lifesciences Ltd.
437.35
5.85 (1.36%)
Jubilant Pharmova Ltd.
977.25
-17.75 (1.78%)
Caplin Point Laboratories Ltd.
2022.00
-2.50 (0.12%)
Dr. Agarwal's Health Care Ltd.
482.00
-2.10 (0.43%)
Alembic Pharmaceuticals Ltd.
725.15
-10.95 (1.49%)
Natco Pharma FAQs
The Buying Price of Natco Pharma share is 947.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Natco Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Natco Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Natco Pharma shares is 12.84. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Natco Pharma shares is 1.97. Useful to assess the stock's value relative to its book value.
To assess Natco Pharma’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of Natco Pharma is 18195.77 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Natco Pharma share price is 1226.80 & 789.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Natco Pharma belongs to the Healthcare sector.
